Verizon Communications Inc. (NYSE:VZ): Current price $45.99
On Monday, Verizon announced that it has expanded the 100G tech on its ultra-long-haul network in the United States and in Europe, adding the technology to over 4,800 miles of its global IP network during the first half of this year. The 100G expansion includes close to 4,500 miles on the Verizon U.S. network, bringing to roughly 21,400 the total number of 100G miles currently deployed on the network.
New 100G routes include Charlotte to Nashville, Seattle to Salt Lake City, Indianapolis to St. Louis, St. Louis to Memphis, and Cleveland to Detroit. Verizon has a goal of deploying an additional 8,700 100G miles in the United States by the end of 2013.
Merck & Co. Inc. (NYSE:MRK): Current price $47.71
Merck reported on Monday that the new drug application for its investigational fertility treatment, corifollitropin alfa, has been accepted for standard review by the FDA. The firm is requesting FDA approval of corifollitropin alfa for controlled ovarian stimulation in women who are participating in assisted reproductive tech. If confirmed, corifollitropin alfa would mark the first sustained follicular stimulant for use in a fertility treatment regimen.
Pfizer Inc. (NYSE: PFE): Current price $28.23
According to Dividend Channel in its most recent DividendRank report, Pfizer has been named the “Top Dividend Stock of the Dow.” The report observed that among the components of the Dow Jones Industrial Average, Pfizer shares exhibited both attractive valuation and strong profitability metrics. The report also pointed out the strong quarterly dividend history at Pfizer and favorable long-term multi-year growth rates in key fundamental data points.
Don’t Miss: Verizon Facing Lawsuit Over Vodafone Buyout.